Skip to content

Marine n-3 Polyunsaturated Fatty Acids in Pre- and Postmenopausal Women

The Incorporation of Marine n-3 Polyunsaturated Fatty Acids in Pre- and Postmenopausal Women: a Randomized Double-Blinded Placebo-Controlled Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00901589
Enrollment
92
Registered
2009-05-14
Start date
2007-08-31
Completion date
2009-05-31
Last updated
2009-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postmenopause, Premenopause

Keywords

n-3 PUFAs, menopause, adipose tissue, estrogens, Incorporation of fishoil in pre- and postmenopausal women, Marine n-3 PUFAs influence on female hormones in blood

Brief summary

The study is a randomised placebo controlled double-blinded clinical trial where a group of healthy pre- and postmenopausal women is randomised to the intake of fish oil capsules or placebo oil capsules for 12 weeks. Anthropometric measurements(weight, height,blood pressure) blood samples and adipose tissue biopsies will be taken in order to illustrate the effect of marine n-3 PUFAs (fish oil) on the concentration of circulating female hormones and to investigate what impact menopause might have on the ability to incorporate marine n-3 PUFAs into tissues.

Interventions

DIETARY_SUPPLEMENTmarine n-3 polyunsaturated fatty acids

Four capsules daily containing 2.2 g marine n-3 polyunsaturated fatty acids in total

DIETARY_SUPPLEMENTthistle oil

four capsules a day

DIETARY_SUPPLEMENTThistle oil

Four capsules daily

Sponsors

Aalborg University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* age 18-70 years old * healthy or well-treated chronic disease

Exclusion criteria

* hormone treatment * foreseen compliance problem * fish oil consumers

Design outcomes

Primary

MeasureTime frame
Content of marine n-PUFAs as percent of total content of fatty acids in adipose tissue and in platelets before and after intervention

Secondary

MeasureTime frame
Measurement of oestrogen concentrations in blood before and after intervention

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026